JACOB QUINN: Open Payments
NPI 1750998704 · WASHINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $310 · 2025 $464
Food & beverage: $379Education: $85
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $141 |
| Lilly USA, LLC | 1 | $96 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| UCB, Inc. | 3 | $76 |
| ABBVIE INC. | 2 | $35 |
| GENZYME CORPORATION | 1 | $24 |
| Organon LLC | 2 | $6 |
Products named: ILUMYA, DUPIXENT, Bimzelx, SKYRIZI, Odomzo.
Industry payments across IL — which companies pay providers there.
